View Full Version : the IQ Corridor
May 6th, 2005, 06:10 PM
what are the relations of the municipalities betweeen Chicago and Mn/SP??
May 7th, 2005, 12:15 AM
I dont follow? :(
May 7th, 2005, 12:23 AM
yea i don't get it either????????????
May 7th, 2005, 12:25 AM
Nor do I.
May 7th, 2005, 03:30 PM
sorry, didn't post the full thread
My question is, what is the relationship between the cities along I-90 from Chicago to the Twin Cities. DSo you agree that it is an evolving "corridor" as the Wisconsin Technology Council claims?
Wisconsin lies at the core of the I-Q Corridor, a region rich in ideas, innovative workers, investment capital and some of the world’s most exciting intellectual property – especially in biotechnology, the life sciences, information technology and advanced manufacturing.
* A distance of only 400 miles separates two dynamos of the Midwest economy – Chicago & the “twin cities” of Minneapolis & St. Paul. That’s a shorter drive or flight than what separates San Diego from the “Silicon Valley” in California.
* Strategically located between Chicago and the Twin Cities and traversed by Interstates 90 and 94 is Wisconsin, one of the nation’s fastest growing technology states in its own right. Wisconsin is ranked in the top 10 for biotechnology employment growth and the number of biotech companies.
* Biotechnology is a $4.9 billion industry in Wisconsin, making up a cluster of about 200 companies employing 28,000.
* Wisconsin provides a complete resource package, from start-up financing to manufacturing and production assistance, uniquely designed to maximize profitability and success for all life science ventures.
* Wisconsin has leading research facilities, growing capital markets, strong partnership organizations, a thriving cluster of science companies and a healthy climate for business, academic & government cooperation.
* Wisconsin has emerging centers of research excellence in tissue regeneration, personalized medicine, error-free hospitals, genetically modified organisms, zoonotics disease control & small molecule pharmaceuticals. Its bioinformatics and medical devices clusters are strong and growing.
But it’s the combined power of the region that makes the “I-Q Corridor” a vibrant location for biotechnology research, technology transfer and company growth.
May 7th, 2005, 03:31 PM
May 7th, 2005, 03:32 PM
Traveling the I-Q Corridor: Upper Midwest technology future is bright
Tom Still • Published 09/15/03
Print this article • E-mail this article • Add your opinion
MADISON – I might just as easily have datelined this column Chicago or Minneapolis, because last week found me in both of the economic powerhouses that bookend the “I-Q Corridor.” It was a reminder that better days lie ahead for Upper Midwest tech companies that have ideas, intellectual property, innovative spirit and investment capital – four of the “I’s” in the I-Q.
The fifth is the interstate highway system that binds Chicago, Milwaukee, the Rockford-Beloit-Janesville area, Madison, the Fox and Chippewa valleys and the Twin Cities of St. Paul and Minneapolis. Within a span of about 400 miles, which is about 100 miles less than what separates California’s high-tech centers of San Diego and San Francisco, lies a significant chunk of the nation’s research universities, tech workers and early-stage companies. There’s also plenty of capital, although not enough is invested in Midwest companies with marketable products in life sciences, information technology and advanced manufacturing. All of the ingredients for success are here.
Although some people in Wisconsin cling to the belief that economic development is accomplished by Madison bashing Milwaukee or Wausau one-upping Stevens Point, the real competition in the 21st century will take place globally. Identifiable regions such as the I-Q Corridor (where the “Q” stands for quality people, schools, lifestyle and environment) will flourish is they can produce globally competitive goods and services.
Wisconsin can win if it leverages its high-tech resources in a way that compliments what’s happening in Chicago and the Twin Cities. The point was hammered home for me in separate trips to both metro areas.
In the Twin Cities, a long history of innovative companies and risk-taking investors has produced one of the nation’s leading medical device clusters and leaders in agribusiness and information technology. The Minnesota Miracle may soon extend to biotechnology, due to the emergence of new state initiatives, cooperation between the University of Minnesota and the Mayo Clinic, and a burst of investment in research buildings.
Tech leaders in Minnesota has decided that the next wave of tech success will be interdisciplinary – with biotechnology, medical devices and IT melding into fields such as bioinformatics. That’s increasingly the approach in Wisconsin, as well, where the UW-Madison, the Medical College of Wisconsin and the Marshfield Clinic are all taking an interdisciplinary approach to research and company spinoffs.
The Twin Cities may also be on the verge of burying a very old hatchet – the rivalry between St. Paul and Minneapolis – to build a biotech incubator on land that straddles the line between both cities. There’s nothing today in Minnesota to match the University Research Park in Madison or the tech transfer ability of the Wisconsin Alumni Research Foundation, but it may only be a matter of time.
In Chicago, the Midwest-Japan Biotechnology Summit provided the latest evidence that the nation’s Heartland is becoming a heart-throb for life science investors and companies. Major Japanese pharmaceutical companies such as Fujisawa, Sankyo and Takeda were on hand to explain why they’re looking for U.S. partners. And there were no shortage of Midwest biotech companies there to listen.
The meeting, sponsored by the Japan External Trade Organization and about 40 Midwest organizations, demonstrated the global nature of tech-based business. Virtually all of the Japanese companies in attendance have long relationships with U.S. markets and suppliers – and they invest on both sides of the Pacific. Likewise, North American pharmaceutical companies at the Chicago summit said they’re working to secure their share of the Japanese market and to invest in its research.
Why are Japanese companies interested in the Midwest? They see it as an emerging cluster of research, workers and start-up companies – and a place where the business deals are less “picked over” than those they may find on the East and West coasts of the United States.
The “I-Q Corridor” is more than a branding slogan. It’s a place where Midwest technology, values and people meet the global economy.
May 7th, 2005, 04:41 PM
Great for the IQ corridor.
Still, this is very ignored.
IQ doesnt sound too good, I would rather call this the ROck River Valley.
May 7th, 2005, 08:52 PM
I really hope that Wisconsin gets the Wisconsin Institute of Discovery built. We really need it.